0001683168-23-009156.txt : 20231229
0001683168-23-009156.hdr.sgml : 20231229
20231229172556
ACCESSION NUMBER: 0001683168-23-009156
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231229
FILED AS OF DATE: 20231229
DATE AS OF CHANGE: 20231229
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thornton Bruce
CENTRAL INDEX KEY: 0001383288
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33216
FILM NUMBER: 231528688
MAIL ADDRESS:
STREET 1: 1129 N. MCDOWELL BLVD.
CITY: PETALUMA
STATE: CA
ZIP: 94954
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sonoma Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001367083
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 680423298
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 5445 CONESTOGA COURT, SUITE 150
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 800-759-9305
MAIL ADDRESS:
STREET 1: 5445 CONESTOGA COURT, SUITE 150
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: Oculus Innovative Sciences, Inc.
DATE OF NAME CHANGE: 20060622
4
1
ownership.xml
X0508
4
2023-12-29
0
0001367083
Sonoma Pharmaceuticals, Inc.
SNOA
0001383288
Thornton Bruce
C/O SONOMA PHARMACEUTICALS, INC.
5445 CONESTOGA COURT, SUITE 150
BOULDER
CO
80301
0
1
0
0
Executive VP & COO
0
Stock option (right to buy)
0.18
2023-12-29
4
A
0
60000
A
2033-12-29
Common Stock
60000
176781
D
The options vest one third each on 12/29/2024, 12/29/2025 and 12/29/2026, or upon change of control or as provided by Mr. Thornton's employment agreement.
The options were awarded and granted to Mr. Thornton for services performed as part of the Company's annual grant of stock options.
/s/ Amy Trombly as attorney-in-fact
2023-12-29